Skip to main content
Log in

Synthesis and Antidepressant Activity of 5-Amine-Substituted 3-Bromo-1-(1,1-Dioxothietan-3-yl)-4-Nitro-1H-Pyrazoles

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

5-Amino-substituted 3-bromo-1-(1,1-dioxothietan-3-yl)-4-nitro-1H-pyrazoles were synthesized via the reactions of 3,5-dibromo-1-(1,1-dioxothietan-3-yl)-4-nitro-1H-pyrazole with aliphatic, aromatic, and heterocyclic amines. The structures of the synthesized compounds were confirmed by IR, PMR, and 13C NMR spectroscopy and mass spectrometry. According to in silico calculations, they were predicted to have no toxic risks (mutagenicity, tumorigenicity, reproductive effects, irritating effects), low toxicity (class IV-V), and acceptable oral bioavailability (based on the topological polar surface area indicator). All synthesized compounds, regardless of the amine structure, showed significant antidepressant activity after a single intraperitoneal injection to male mice in the forced swimming test that was comparable to that of amitriptyline, while 1-[3-bromo-1-(1,1-dioxothietan-3-yl)-4-nitro-1H-pyrazol-5-yl]-4-methylpiperazine (compound IIi) had a significant sedative effect in the open field test. The results of a comprehensive assessment of the biological activity of the synthesized compounds in vivo/in silico indicated that the class of 5-amino-substituted pyrazole derivatives was promising for further research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. A. Trabocchi and E. Lenci (eds.), Small Molecule Drug Discovery, Elsevier (2020), pp. xv-xvi.

  2. N. A. McGrath, M. Brichacek, and J. T. Njardarson, J. Chem. Educ., 87(12), 1348 – 1349 (2010).

    Article  CAS  Google Scholar 

  3. Mepiprezole in DrugBank database: https://www.drugbank.ca/drugs/DB09197.

  4. E. R. Baizman, A. M. Ezrin, R. A. Ferrari, and D. Luttinger, J. Pharmacol. Exp. Ther., 243(1), 40 – 54 (1987).

    CAS  PubMed  Google Scholar 

  5. M. N. Modica, E. Lacivita, S. Intagliata, et al., J. Med. Chem., 61(19), 8475 – 8503 (2018).

    Article  CAS  PubMed  Google Scholar 

  6. O. Soler-Cedeno and Z.-X. Xi, Cells, 11(20), 3262 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. F. A. Khaliullin, I. L. Nikitina, E. E. Klen, et al., Khim.-farm. Zh., 53(12), 8 – 15 (2020).

    Google Scholar 

  8. I. L. Nikitina and G. G. Gaisina, Res. Results Pharmacol., 7(3), 63 – 71 (2021).

    Article  CAS  Google Scholar 

  9. F. A. Khaliullin, I. L. Nikitina, E. E. Klen, et al., Khim.-farm. Zh., 55(2), 13 – 19 (2021).

    Google Scholar 

  10. F. A. Khaliullin, E. E. Klen, I. L. Nikitina, et al., Khim.-farm. Zh., 56(12), 27 – 34 (2022).

    Google Scholar 

  11. E. E. Klen, N. N. Makarova, F. A. Khaliullin, et al., Kh. Org. Khim., 58(9), 926 – 935 (2022).

    Google Scholar 

  12. S. Lesniak, W. J. Kinart, and J. Lewkowski, in: Comprehensive Heterocyclic Chemistry III, A. R. Katritzky, C. A. Ramsden, E. F. V. Scriven, and R. J. K. Taylor (eds.), Oxford (2008), pp. 389 – 428.

  13. F. A. Khaliullin, E. E. Klen, V. N. Pavlov, et al., Khim.-farm. Zh., 56(3), 15 – 20 (2022).

    Google Scholar 

  14. T. Sander, J. Freyss, M. von Korff, and C. Rufener, J. Chem. Inf. Model., 55(2), 460 – 473 (2015).

    Article  CAS  PubMed  Google Scholar 

  15. A. Daina, O. Michielin, and V. Zoete, Sci. Rep., 7, 42717 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  16. A. A. Lagunin, A. V. Zakharov, D. S. Filimonov, et al., Mol. Inf., 30(2 – 3), 241 – 250 (2011).

    Article  CAS  Google Scholar 

  17. L. Steru, Psychopharmacology, 85(3), 367 – 370 (1985).

    Article  CAS  PubMed  Google Scholar 

  18. E. V. Shchetinin, V. A. Baturin, E. B. Arushanyan, et al., Zh. Vyssh. Nervn. Deyat., No. 39, 958 – 964 (1989).

  19. A. V. Val?dman and V. P. Poshivalov, Pharmacological Regulation of Intraspecies Behavior [in Russian], Meditsina, Leningrad (1984).

  20. European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, ETS No. 123, Strasbourg (1986).

  21. Decision of the EEC Council of Nov. 3, 2016, No. 81 “On Approval of Good Laboratory Practice Rules of the Eurasian Economic Union on Drug Circulation” [in Russian], (2020).

  22. Certificate of State Registration of Computer Program No. 2008610170, Russia (2008).

  23. A. M. Grzhibovskii, S. V. Ivanov, and M. A. Gorbatova, Nauka Zdravookhr., No. 3, 5 – 25 (2016).

  24. A. M. Grzhibovskii, S. V. Ivanov, and M. A. Gorbatova, Nauka Zdravookhr., No. 1, 7 – 23 (2016).

  25. GOST 12.1.007–76 System of Labor Safety Standards (SSBT). Hazardous substances. Classification and general safety requirements (with amendments No. 1 and 2) of Mar. 10, 1976 (2022).

  26. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, Adv. Drug Deliv. Rev., 23(1 – 3), 3 – 25 (1997).

    Article  CAS  Google Scholar 

  27. D. F. Veber, S. R. Johnson, H.-Y. Cheng, et al., J. Med. Chem., 45(12), 2615 – 2623 (2002).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. A. Khaliullin.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 7, pp. 33 – 40, July, 2023.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klen, E.E., Nikitina, I.L., Khaliullin, F.A. et al. Synthesis and Antidepressant Activity of 5-Amine-Substituted 3-Bromo-1-(1,1-Dioxothietan-3-yl)-4-Nitro-1H-Pyrazoles. Pharm Chem J 57, 1202–1209 (2023). https://doi.org/10.1007/s11094-024-03027-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-024-03027-y

Keywords

Navigation